Study Of Safety, Blood Levels, And Brain Receptor Occupancy Of GSK163090 Using PET Imaging In Healthy Males
Status:
Completed
Trial end date:
2007-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to look at how much of a new drug, GSK163090, binds to proteins
in the brain and how much stays in the blood over a range of different doses. This study will
use a medical imaging technique called Positron Emission Tomography (PET) which uses an
imaging agent called [11C]-WAY100635.